AU2013904239A0 - Pharmaceutical combinations for the treatment of cancer - Google Patents

Pharmaceutical combinations for the treatment of cancer

Info

Publication number
AU2013904239A0
AU2013904239A0 AU2013904239A AU2013904239A AU2013904239A0 AU 2013904239 A0 AU2013904239 A0 AU 2013904239A0 AU 2013904239 A AU2013904239 A AU 2013904239A AU 2013904239 A AU2013904239 A AU 2013904239A AU 2013904239 A0 AU2013904239 A0 AU 2013904239A0
Authority
AU
Australia
Prior art keywords
cancer
treatment
pharmaceutical combinations
pharmaceutical
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013904239A
Inventor
Roger Aston
David Lawson Morris
Mohammad Hossein Pourgholami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NewSouth Innovations Pty Ltd
Pitney Pharmaceuticals Pty Ltd
Original Assignee
NewSouth Innovations Pty Ltd
Pitney Pharmaceuticals Pty Ltd
Filing date
Publication date
Application filed by NewSouth Innovations Pty Ltd, Pitney Pharmaceuticals Pty Ltd filed Critical NewSouth Innovations Pty Ltd
Publication of AU2013904239A0 publication Critical patent/AU2013904239A0/en
Priority to PCT/AU2014/001017 priority Critical patent/WO2015061832A1/en
Priority to KR1020167008078A priority patent/KR102271848B1/en
Priority to CN201480052310.6A priority patent/CN105792823B/en
Priority to US15/021,217 priority patent/US9833431B2/en
Priority to EP14859220.7A priority patent/EP3062790B1/en
Priority to NZ716765A priority patent/NZ716765A/en
Priority to PL14859220.7T priority patent/PL3062790T3/en
Priority to JP2016524588A priority patent/JP2016535014A/en
Priority to CA2922575A priority patent/CA2922575C/en
Priority to ES14859220T priority patent/ES2940890T3/en
Priority to AU2014344789A priority patent/AU2014344789B2/en
Priority to HK16110698.6A priority patent/HK1222548A1/en
Priority to JP2019044801A priority patent/JP6666494B2/en
Abandoned legal-status Critical Current

Links

AU2013904239A 2013-11-01 2013-11-01 Pharmaceutical combinations for the treatment of cancer Abandoned AU2013904239A0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
AU2014344789A AU2014344789B2 (en) 2013-11-01 2014-10-31 Pharmaceutical combinations for the treatment of cancer
PL14859220.7T PL3062790T3 (en) 2013-11-01 2014-10-31 Pharmaceutical combinations for the treatment of cancer
JP2016524588A JP2016535014A (en) 2013-11-01 2014-10-31 Medicinal combination for the treatment of cancer
CN201480052310.6A CN105792823B (en) 2013-11-01 2014-10-31 The pharmaceutical composition for treating malignant tumour
US15/021,217 US9833431B2 (en) 2013-11-01 2014-10-31 Pharmaceutical combinations for the treatment of cancer
EP14859220.7A EP3062790B1 (en) 2013-11-01 2014-10-31 Pharmaceutical combinations for the treatment of cancer
NZ716765A NZ716765A (en) 2013-11-01 2014-10-31 Pharmaceutical combinations for the treatment of cancer
PCT/AU2014/001017 WO2015061832A1 (en) 2013-11-01 2014-10-31 Pharmaceutical combinations for the treatment of cancer
KR1020167008078A KR102271848B1 (en) 2013-11-01 2014-10-31 Pharmaceutical combinations for the treatment of cancer
CA2922575A CA2922575C (en) 2013-11-01 2014-10-31 Pharmaceutical combinations for the treatment of cancer
ES14859220T ES2940890T3 (en) 2013-11-01 2014-10-31 Pharmaceutical combinations for the treatment of cancer
HK16110698.6A HK1222548A1 (en) 2013-11-01 2016-09-08 Pharmaceutical combinations for the treatment of cancer
JP2019044801A JP6666494B2 (en) 2013-11-01 2019-03-12 Pharmaceutical combinations for the treatment of cancer

Publications (1)

Publication Number Publication Date
AU2013904239A0 true AU2013904239A0 (en) 2013-11-21

Family

ID=

Similar Documents

Publication Publication Date Title
EP3027192A4 (en) Methods for the treatment of solid tumors
EP3030323A4 (en) Kdm1a inhibitors for the treatment of disease
EP2964028A4 (en) Compounds for treatment of cancer
EP3076977A4 (en) Combination therapy for treating cancer
EP3033079A4 (en) Methods for the treatment of her2 amplified cancer
SI3033086T1 (en) Combination therapy for the treatment of cancer
EP3038647A4 (en) Combination therapy for the treatment of glioblastoma
EP3148532A4 (en) Pharmaceutical combination for the treatment of cancer
EP3389645A4 (en) Combinations for the treatment of cancer
EP3436002A4 (en) Pharmaceutical combinations for the treatment of cancer
EP2994148B8 (en) Cancer therapy
PT3089749T (en) Combined preparations for the treatment of cancer
HK1222548A1 (en) Pharmaceutical combinations for the treatment of cancer
EP3004396A4 (en) Methods and compositions for the treatment of cancer
EP3132802A4 (en) Therapeutic agent for solid cancer
EP3007756A4 (en) Catheter-assisted tumor treatment
EP3008212A4 (en) Methods of treatment of cancer
EP2994155A4 (en) Targeting the egfr-sglt1 interaction for cancer therapy
HK1219737A1 (en) Novel compounds for the treatment of cancer
EP3044593A4 (en) Cancer therapy
EP3003489A4 (en) Cytotoxic agents for the treatment of cancer
EP3057593A4 (en) Treatment for pancreatic cancer
HK1223547A1 (en) Methods for the treatment of cancer
EP3046556A4 (en) Combination drug therapy
EP3089745A4 (en) Compounds, compositions, and methods for the treatment of cancers